AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
My Activity
EN
Login
EN
Surge Analysis
/
Fennec Pharmaceuticals Inc.
/
2026-05-14
▲ SURGE
Fennec Pharmaceuticals Inc.
+36.3%
FENC
NASDAQ
Healthcare
2026-05-14
9.23
Close
6.77
Prev Close
+36.34%
Change
29.6x
Vol Ratio
Why It Surged
Fennec Pharmaceuticals는 2025년에 PEDMARK의 기록적인 매출을 달성했다고 2026년 3월 27일 발표했다.
·
Fennec Pharmaceuticals는 2025년에 PEDMARK의 기록적인 매출을 달성했다고 2026년 3월 27일 발표했다.
·
2026년 5월 14일 발표된 1분기 주당순이익(EPS)은 $0.01로, 시장 예상치인 $(0.02)를 상회했다.
·
2026년 1분기 매출액은 1,510.8만 달러($15.108M)를 기록하여 시장 예상치인 1,395.4만 달러($13.954M)를 초과 달성했다.
Related News
Fennec Posts Record PEDMARK Sales in 2025 as Clinical and Commercial Momentum Builds
Tipranks
2026-03-27
Fennec Pharmaceuticals Q1 EPS $0.01 Beats $(0.02) Estimate, Sales $15.108M Beat $13.954M Estimate
Benzinga
2026-05-14
Neuren Updates Market on Progress of On-Market Share Buy-Back
Tipranks
2026-04-16
Neuren Pharmaceuticals Updates Market on Ongoing Share Buy-Back
Tipranks
2026-04-19
NRx Pharmaceuticals, Inc. (NRXP) Stock Price, News, Quote & History
Ca.Finance.Yahoo
2026-03-07
Technical Analysis
Signals
BB Upper Break
Overbought
MACD Bullish
Above SMA20
Key Indicators
74.39
RSI (14)
6.88
SMA 20
5.69
Bollinger Lower
8.07
Bollinger Upper
6.88
Bollinger Mid
0.25
MACD
0.07
MACD Signal
0.19
MACD Hist
View Company
Back to Surge Stocks
Home
Chat
Portfolio
Activity
Menu
Fennec Pharmaceuticals Inc. Surged +36.3% on 2026-05-14 — Analysis | Alpha Lenz